Right Ventricular Failure in Patients with Left Ventricular Assist Devices

Cardiology Clinics

Volumn 30, Issue 2, 2012, Pages 291-302

  Rich, Jonathan D ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

Heart failure; Left ventricular assist device; Mechanical circulatory support; Right ventricle; Treatment; Ventricular assist device

Indexed keywords

INOTROPIC AGENT; NITRIC OXIDE;

CARDIOPULMONARY BYPASS; CONGESTIVE HEART FAILURE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; HEART AFTERLOAD; HEART ASSIST DEVICE; HEART LEFT VENTRICLE FAILURE; HEART PRELOAD; HEART RIGHT VENTRICLE FAILURE; HEART VENTRICLE CONTRACTILITY; HUMAN; PATHOPHYSIOLOGY; PERIOPERATIVE PERIOD; POSTOPERATIVE CARE; PREDICTION; PREOPERATIVE CARE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RETROSPECTIVE STUDY; REVIEW; SYSTOLIC BLOOD PRESSURE; TREATMENT RESPONSE;

CARDIAC OUTPUT; HEART FAILURE; HEART-ASSIST DEVICES; HUMANS; INTRAOPERATIVE CARE; MYOCARDIAL CONTRACTION; POSTOPERATIVE CARE; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR DYSFUNCTION, RIGHT;

EID: 84860366635     PISSN: 07338651     EISSN: 15582264     Source Type: Journal    
DOI: 10.1016/j.ccl.2012.03.008     Document Type: Review

References (68)

1. Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) Quarterly Statistical Summary Report. The Data Collection and Analysis Center at the University of Alabama at Birmingham. 2011.
2. Starling R.C., Gorodeski E.Z. Potential population for long-term use of left ventricular assist devices. Mechanical circulatory support: a companion to Braunwald's heart disease 2011, 11-21. Elsevier, Philadelphia (PA). R.L. Kormos, L.W. Miller (Eds.).
3. Taylor D.O., Stehlik J., Edwards L.B., et al. Registry of the international society for heart and lung transplantation: twenty-sixth official adult heart transplant report-2009. J Heart Lung Transplant 2009, 28(10):1007-1022.
4. Rose E.A., Gelijns A.C., Moskowitz A.J., et al. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 2001, 345(20):1435-1443.
5. Slaughter M.S., Rogers J.G., Milano C.A., et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med 2009, 361(23):2241-2251.
6. Kavarana M.N., Pessin-Minsley M.S., Urtecho J., et al. Right ventricular dysfunction and organ failure in left ventricular assist device recipients: a continuing problem. Ann Thorac Surg 2002, 73(3):745-750.
7. Kormos R.L., Teuteberg J.J., Pagani F.D., et al. Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes. J Thorac Cardiovasc Surg 2010, 139(5):1316-1324.
8. Genovese E.A., Dew M.A., Teuteberg J.J., et al. Incidence and patterns of adverse event onset during the first 60 days after ventricular assist device implantation. Ann Thorac Surg 2009, 88(4):1162-1170.
9. Dang N.C., Topkara V.K., Mercando M., et al. Right heart failure after left ventricular assist device implantation in patients with chronic congestive heart failure. J Heart Lung Transplant 2006, 25(1):1-6.
10. Kukucka M., Stepanenko A., Potapov E., et al. Right-to-left ventricular end-diastolic diameter ratio and prediction of right ventricular failure with continuous-flow left ventricular assist devices. J Heart Lung Transplant 2011, 30(1):64-69.
11. Kormos R.L., Gasior T.A., Kawai A., et al. Transplant candidate's clinical status rather than right ventricular function defines need for univentricular versus biventricular support. J Thorac Cardiovasc Surg 1996, 111(4):773-782. [discussion: 782-3].
12. Morgan J.A., John R., Lee B.J., et al. Is severe right ventricular failure in left ventricular assist device recipients a risk factor for unsuccessful bridging to transplant and post-transplant mortality. Ann Thorac Surg 2004, 77(3):859-863.
13. Drakos S.G., Janicki L., Horne B.D., et al. Risk factors predictive of right ventricular failure after left ventricular assist device implantation. Am J Cardiol 2010, 105(7):1030-1035.
14. Patel N.D., Weiss E.S., Schaffer J., et al. Right heart dysfunction after left ventricular assist device implantation: a comparison of the pulsatile HeartMate I and axial-flow HeartMate II devices. Ann Thorac Surg 2008, 86(3):832-840. [discussion: 832-40].
15. Baumwol J., Macdonald P.S., Keogh A.M., et al. Right heart failure and " failure to thrive" after left ventricular assist device: clinical predictors and outcomes. J Heart Lung Transplant 2011, 30(8):888-895.
16. Potapov E.V., Stepanenko A., Dandel M., et al. Tricuspid incompetence and geometry of the right ventricle as predictors of right ventricular function after implantation of a left ventricular assist device. J Heart Lung Transplant 2008, 27(12):1275-1281.
17. Lietz K., Long J.W., Kfoury A.G., et al. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection. Circulation 2007, 116(5):497-505.
18. Matthews J.C., Koelling T.M., Pagani F.D., et al. The right ventricular failure risk score a pre-operative tool for assessing the risk of right ventricular failure in left ventricular assist device candidates. J Am Coll Cardiol 2008, 51(22):2163-2172.
19. Santambrogio L., Bianchi T., Fuardo M., et al. Right ventricular failure after left ventricular assist device insertion: preoperative risk factors. Interact Cardiovasc Thorac Surg 2006, 5(4):379-382.
20. Farrar D.J., Hill J.D., Pennington D.G., et al. Preoperative and postoperative comparison of patients with univentricular and biventricular support with the Thoratec ventricular assist device as a bridge to cardiac transplantation. J Thorac Cardiovasc Surg 1997, 113(1):202-209.
21. Fitzpatrick J.R., Frederick J.R., Hsu V.M., et al. Risk score derived from pre-operative data analysis predicts the need for biventricular mechanical circulatory support. J Heart Lung Transplant 2008, 27(12):1286-1292.
22. Fukamachi K., McCarthy P.M., Smedira N.G., et al. Preoperative risk factors for right ventricular failure after implantable left ventricular assist device insertion. Ann Thorac Surg 1999, 68(6):2181-2184.
23. Haddad F., Hunt S.A., Rosenthal D.N., et al. Right ventricular function in cardiovascular disease, part I: anatomy, physiology, aging, and functional assessment of the right ventricle. Circulation 2008, 117(11):1436-1448.
24. Santamore W.P., Dell'Italia L.J. Ventricular interdependence: significant left ventricular contributions to right ventricular systolic function. Prog Cardiovasc Dis 1998, 40(4):289-308.
25. Saleh S., Liakopoulos O.J., Buckberg G.D. The septal motor of biventricular function. Eur J Cardiothorac Surg 2006, 29(Suppl 1):S126-S138.
26. Janicki J.S., Weber K.T. The pericardium and ventricular interaction, distensibility, and function. Am J Physiol 1980, 238(4):H494-H503.
27. Farrar D.J., Compton P.G., Hershon J.J., et al. Right heart interaction with the mechanically assisted left heart. World J Surg 1985, 9(1):89-102.
28. Tedford R.J., Hassoun P.M., Mathai S.C., et al. Pulmonary capillary wedge pressure augments right ventricular pulsatile loading. Circulation 2012, 125(2):289-297.
29. Farrar D.J., Compton P.G., Dajee H., et al. Right heart function during left heart assist and the effects of volume loading in a canine preparation. Circulation 1984, 70(4):708-716.
30. Morita S., Kormos R.L., Mandarino W.A., et al. Right ventricular/arterial coupling in the patient with left ventricular assistance. Circulation 1992, 86(Suppl 5):II316-II325.
31. John R., Liao K., Kamdar F., et al. Effects on pre- and posttransplant pulmonary hemodynamics in patients with continuous-flow left ventricular assist devices. J Thorac Cardiovasc Surg 2010, 140(2):447-452.
32. Alba A.C., Rao V., Ross H.J., et al. Impact of fixed pulmonary hypertension on post-heart transplant outcomes in bridge-to-transplant patients. J Heart Lung Transplant 2010, 29(11):1253-1258.
33. Etz C.D., Welp H.A., Tjan T.D., et al. Medically refractory pulmonary hypertension: treatment with nonpulsatile left ventricular assist devices. Ann Thorac Surg 2007, 83(5):1697-1705.
34. Zener J.C., Hancock E.W., Shumway N.E., et al. Regression of extreme pulmonary hypertension after mitral valve surgery. Am J Cardiol 1972, 30(8):820-826.
35. Deswarte G., Kirsch M., Lesault P.F., et al. Right ventricular reserve and outcome after continuous-flow left ventricular assist device implantation. J Heart Lung Transplant 2010, 29(10):1196-1198.
36. Weber K.T., Janicki J.S., Shroff S., et al. Contractile mechanics and interaction of the right and left ventricles. Am J Cardiol 1981, 47(3):686-695.
37. Damiano R.J., La Follette P., Cox J.L., et al. Significant left ventricular contribution to right ventricular systolic function. Am J Physiol 1991, 261(5 Pt 2):H1514-H1524.
38. Li K.S., Santamore W.P. Contribution of each wall to biventricular function. Cardiovasc Res 1993, 27(5):792-800.
39. Santamore W.P., Lynch P.R., Heckman J.L., et al. Left ventricular effects on right ventricular developed pressure. J Appl Physiol 1976, 41(6):925-930.
40. Hoffman D., Sisto D., Frater R.W., et al. Left-to-right ventricular interaction with a noncontracting right ventricle. J Thorac Cardiovasc Surg 1994, 107(6):1496-1502.
41. Goldstein J.A., Tweddell J.S., Barzilai B., et al. Importance of left ventricular function and systolic ventricular interaction to right ventricular performance during acute right heart ischemia. J Am Coll Cardiol 1992, 19(3):704-711.
42. Dibble C.T., Lima J.A., Bluemke D.A., et al. Regional left ventricular systolic function and the right ventricle: the multi-ethnic study of atherosclerosis right ventricle study. Chest 2011, 140(2):310-316.
43. Farrar D.J. Physiology of ventricular interactions during ventricular assistance 2000, Futura Publishing Co., Inc, Armonk (NY).
44. Klima U.P., Lee M.Y., Guerrero J.L., et al. Determinants of maximal right ventricular function: role of septal shift. J Thorac Cardiovasc Surg 2002, 123(1):72-80.
45. Bocchi E.A., Bacal F., Auler Junior J.O., et al. Inhaled nitric oxide leading to pulmonary edema in stable severe heart failure. Am J Cardiol 1994, 74(1):70-72.
46. Dickstein M.L., Burkhoff D. A theoretic analysis of the effect of pulmonary vasodilation on pulmonary venous pressure: implications for inhaled nitric oxide therapy. J Heart Lung Transplant 1996, 15(7):715-721.
47. Fitzpatrick J.R., Frederick J.R., Hiesinger W., et al. Early planned institution of biventricular mechanical circulatory support results in improved outcomes compared with delayed conversion of a left ventricular assist device to a biventricular assist device. J Thorac Cardiovasc Surg 2009, 137(4):971-977.
48. Loforte A., Montalto A., Lilla Della Monica P., et al. Simultaneous temporary CentriMag right ventricular assist device placement in HeartMate II left ventricular assist system recipients at high risk of right ventricular failure. Interact Cardiovasc Thorac Surg 2010, 10(6):847-850.
49. Bhama J.K., Kormos R.L., Toyoda Y., et al. Clinical experience using the Levitronix CentriMag system for temporary right ventricular mechanical circulatory support. J Heart Lung Transplant 2009, 28(9):971-976.
50. Puwanant S., Hamilton K.K., Klodell C.T., et al. Tricuspid annular motion as a predictor of severe right ventricular failure after left ventricular assist device implantation. J Heart Lung Transplant 2008, 27(10):1102-1107.
51. Lee S., Kamdar F., Madlon-Kay R., et al. Effects of the HeartMate II continuous-flow left ventricular assist device on right ventricular function. J Heart Lung Transplant 2010, 29(2):209-215.
52. Saeed D., Kidambi T., Shalli S., et al. Tricuspid valve repair with left ventricular assist device implantation: is it warranted?. J Heart Lung Transplant 2011, 30(5):530-535.
53. Piacentino V., Troupes C.D., Ganapathi A.M., et al. Clinical impact of concomitant tricuspid valve procedures during left ventricular assist device implantation. Ann Thorac Surg 2011, 92(4):1414-1418. [discussion: 1418-9].
54. Daly R.C., Chandrasekaran K., Cavarocchi N.C., et al. Ischemia of the interventricular septum. A mechanism of right ventricular failure during mechanical left ventricular assist. J Thorac Cardiovasc Surg 1992, 103(6):1186-1191.
55. Pegg T.J., Selvanayagam J.B., Karamitsos T.D., et al. Effects of off-pump versus on-pump coronary artery bypass grafting on early and late right ventricular function. Circulation 2008, 117(17):2202-2210.
56. Feneck R.O., Sherry K.M., Withington P.S., et al. Comparison of the hemodynamic effects of milrinone with dobutamine in patients after cardiac surgery. J Cardiothorac Vasc Anesth 2001, 15(3):306-315.
57. Packer M. Vasodilator therapy for primary pulmonary hypertension. Limitations and hazards. Ann Intern Med 1985, 103(2):258-270.
58. Argenziano M., Choudhri A.F., Moazami N., et al. Randomized, double-blind trial of inhaled nitric oxide in LVAD recipients with pulmonary hypertension. Ann Thorac Surg 1998, 65(2):340-345.
59. Kukucka M., Potapov E., Stepanenko A., et al. Acute impact of left ventricular unloading by left ventricular assist device on the right ventricle geometry and function: effect of nitric oxide inhalation. J Thorac Cardiovasc Surg 2011, 141(4):1009-1014.
60. Potapov E., Meyer D., Swaminathan M., et al. Inhaled nitric oxide after left ventricular assist device implantation: a prospective, randomized, double-blind, multicenter, placebo-controlled trial. J Heart Lung Transplant 2011, 30(8):870-878.
61. Tedford R.J., Hemnes A.R., Russell S.D., et al. PDE5A inhibitor treatment of persistent pulmonary hypertension after mechanical circulatory support. Circ Heart Fail 2008, 1(4):213-219.
62. Nagendran J., Archer S.L., Soliman D., et al. Phosphodiesterase type 5 is highly expressed in the hypertrophied human right ventricle, and acute inhibition of phosphodiesterase type 5 improves contractility. Circulation 2007, 116(3):238-248.
63. Di Salvo T.G., Mathier M., Semigran M.J., et al. Preserved right ventricular ejection fraction predicts exercise capacity and survival in advanced heart failure. J Am Coll Cardiol 1995, 25(5):1143-1153.
64. Barbone A., Holmes J.W., Heerdt P.M., et al. Comparison of right and left ventricular responses to left ventricular assist device support in patients with severe heart failure: a primary role of mechanical unloading underlying reverse remodeling. Circulation 2001, 104(6):670-675.
65. Maeder M.T., Leet A., Ross A., et al. Changes in right ventricular function during continuous-flow left ventricular assist device support [corrected]. J Heart Lung Transplant 2009, 28(4):360-366.
66. Palardy M., Nohria A., Rivero J., et al. Right ventricular dysfunction during intensive pharmacologic unloading persists after mechanical unloading. J Card Fail 2010, 16(3):218-224.
67. Loforte A., Monica P.L., Montalto A., et al. HeartWare third-generation implantable continuous flow pump as biventricular support: mid-term follow-up. Interact Cardiovasc Thorac Surg 2011, 12(3):458-460.
68. Ochiai Y., McCarthy P.M., Smedira N.G., et al. Predictors of severe right ventricular failure after implantable left ventricular assist device insertion: analysis of 245 patients. Circulation 2002, 106(12 Suppl 1):I198-I202.